Nearly all researchers see amyloid plaques as a danger factor for Alzheimer’s.
Nevertheless, this research presents the poisonous, sticky protein as a part of the illness — the earliest precursor earlier than signs arise.
“To have the best influence on the disease, we need to intervene towards amyloid, the essential molecular cause, as early as potential,” stated Paul Aisen, senior writer of the research and director of the USC Alzheimer’s Therapeutic Research Institute (ATRI) on the Keck Faculty of Drugs. “This research is a big step toward the concept elevated amyloid levels are an early stage of Alzheimer’s, an applicable stage for anti-amyloid therapy.”
Notably, the incubation interval with elevated amyloid plaques — the asymptomatic stage — can last more than the dementia stage.
“This research is making an attempt to help the idea that the disease starts earlier than signs, which lays the groundwork for conducting early interventions,” stated Michael Donohue, lead writer of the research and an associate professor of neurology at USC ATRI.
Other articles you might like;
- Colour-changing tattoo ink could help people with diabetes
- Scientists reveal THIS technique can make you lose 2.5st in four months – without dieting
- ‘Alexa, what’s my blood sugar level and how much insulin should I take?’
- The Truth Behind Common Apple Cider Vinegar Uses You've Likely Heard Before
- Eating red onions ‘can prevent cancer’ and could protect against diabetes and heart disease